Canada Gene Synthesis Market Size & Outlook, 2022-2030
Canada gene synthesis market, 2018-2030 (US$M)
Related Markets
Canada gene synthesis market highlights
- The Canada gene synthesis market generated a revenue of USD 75.5 million in 2022 and is expected to reach USD 236.6 million by 2030.
- The Canada market is expected to grow at a CAGR of 15.3% from 2023 to 2030.
- In terms of segment, solid-phase synthesis was the largest revenue generating method in 2022.
- PCR-based Enzyme Synthesis is the most lucrative method segment registering the fastest growth during the forecast period.
Gene synthesis market data book summary
| Market revenue in 2022 | USD 75.5 million |
| Market revenue in 2030 | USD 236.6 million |
| Growth rate | 15.3% (CAGR from 2022 to 2030) |
| Largest segment | Solid-phase synthesis |
| Fastest growing segment | PCR-based Enzyme Synthesis |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
| Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
Other key industry trends
- In terms of revenue, Canada accounted for 4.3% of the global gene synthesis market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. gene synthesis market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,964.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Synthesis Market Scope
Gene Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada gene synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 35.76% in 2022. Horizon Databook has segmented the Canada gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is globally well-positioned in the field of biotechnology and ranks second behind the U.S. in number of biotech firms in North America. Its advanced R&D infrastructure supports innovation, and the country has the second-highest concentration of biotechnology firms in the region.
The Canadian government provides hosting condition to create a healthy ecosystem that can attract investment for growth of the biotech industry. The confluence of abovementioned factors is anticipated to boost research activities in biotechnology & pharmaceutical fields, which are, in turn, supplementing the growth of gene synthesis market.
Furthermore, the country’s market is expected to register significant growth over the forecast period owing to ongoing development and advancement initiatives undertaken by institutions such as National Research Council Canada, which monitors and offers bioconversion & bioprocessing services.
Reasons to subscribe to Canada gene synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada gene synthesis market databook
-
Our clientele includes a mix of gene synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada gene synthesis market, including forecasts for subscribers. This country databook contains high-level insights into Canada gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada gene synthesis market report size, by method, 2018-2030 (US$M)
Canada Gene Synthesis Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
